These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27987545)

  • 1. Podocyte-Targeted Treatment for Proteinuric Kidney Disease.
    Mundel P
    Semin Nephrol; 2016 Nov; 36(6):459-462. PubMed ID: 27987545
    [No Abstract]   [Full Text] [Related]  

  • 2. Abatacept in B7-1-positive proteinuric kidney disease.
    Yu CC; Fornoni A; Weins A; Hakroush S; Maiguel D; Sageshima J; Chen L; Ciancio G; Faridi MH; Behr D; Campbell KN; Chang JM; Chen HC; Oh J; Faul C; Arnaout MA; Fiorina P; Gupta V; Greka A; Burke GW; Mundel P
    N Engl J Med; 2013 Dec; 369(25):2416-23. PubMed ID: 24206430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of B7-1 in proteinuria of glomerular origin.
    Novelli R; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2018 Sep; 14(9):589-596. PubMed ID: 29959373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.
    Burke GW; Chandar J; Sageshima J; Ortigosa-Goggins M; Amarapurkar P; Mitrofanova A; Defreitas MJ; Katsoufis CP; Seeherunvong W; Centeno A; Pagan J; Mendez-Castaner LA; Mattiazzi AD; Kupin WL; Guerra G; Chen LJ; Morsi M; Figueiro JMG; Vianna R; Abitbol CL; Roth D; Fornoni A; Ruiz P; Ciancio G; Garin EH
    Pediatr Nephrol; 2023 Jan; 38(1):145-159. PubMed ID: 35507150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B7-1 Blockade Does Not Improve Post-Transplant Nephrotic Syndrome Caused by Recurrent FSGS.
    Delville M; Baye E; Durrbach A; Audard V; Kofman T; Braun L; Olagne J; Nguyen C; Deschênes G; Moulin B; Delahousse M; Kesler-Roussey G; Beaudreuil S; Martinez F; Rabant M; Grimbert P; Gallazzini M; Terzi F; Legendre C; Canaud G
    J Am Soc Nephrol; 2016 Aug; 27(8):2520-7. PubMed ID: 26701979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Anti-Nephrin Antibody Mediated Podocyte Injury Model Using a C57BL/6 Mouse Strain.
    Takeuchi K; Naito S; Kawashima N; Ishigaki N; Sano T; Kamata K; Takeuchi Y
    Nephron; 2018; 138(1):71-87. PubMed ID: 28965116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Any value of podocyte B7-1 as a biomarker in human MCD and FSGS?
    Novelli R; Gagliardini E; Ruggiero B; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F335-41. PubMed ID: 26697986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary CD80 as a Replacement for Renal Biopsy for Diagnosis of Pediatric Minimal Change Disease.
    Ahmed HM; Ezzat DA; Doudar NA; Adel M
    Iran J Kidney Dis; 2018 Mar; 12(2):107-111. PubMed ID: 29507273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful Treatment With Abatacept in Recurrent Focal Segmental Glomerulosclerosis After Kidney Transplant.
    Shah Y; Almeshari K; Aleid H; Broering D; Alahmadi I; Ali T
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):178-180. PubMed ID: 30777550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of abatacept treatment for focal segmental glomerulosclerosis and minimal change disease: A systematic review of case reports, case series, and observational studies
.
    Hansrivijit P; Puthenpura MM; Ghahramani N
    Clin Nephrol; 2020 Sep; 94(3):117-126. PubMed ID: 32589135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new era of podocyte-targeted therapy for proteinuric kidney disease.
    Haraldsson B
    N Engl J Med; 2013 Dec; 369(25):2453-4. PubMed ID: 24206429
    [No Abstract]   [Full Text] [Related]  

  • 12. Developing therapeutic 'arrows' with the precision of William Tell: the time has come for targeted therapies in kidney disease.
    Mundel P; Greka A
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):388-92. PubMed ID: 26050127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abatacept and Glomerular Diseases: The Open Road for the Second Signal as a New Target is Settled Down.
    Trimarchi H
    Recent Pat Endocr Metab Immune Drug Discov; 2015; 9(1):2-14. PubMed ID: 25733062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Effects of Immunomodulatory Agents on Podocytes in Immune-Mediated Glomerular Diseases.
    Manabe S; Nitta K; Nagata M
    Contrib Nephrol; 2018; 195():131-142. PubMed ID: 29734158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte Expression of B7-1/CD80: Is it a Reliable Biomarker for the Treatment of Proteinuric Kidney Diseases with Abatacept?
    Salant DJ
    J Am Soc Nephrol; 2016 Apr; 27(4):963-5. PubMed ID: 26400567
    [No Abstract]   [Full Text] [Related]  

  • 16. Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis.
    Hirakawa M; Tsuruya K; Yotsueda H; Tokumoto M; Ikeda H; Katafuchi R; Fujimi S; Hirakata H; Iida M
    Life Sci; 2006 Jul; 79(8):757-63. PubMed ID: 16564554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case series: CTLA4-IgG1 therapy in minimal change disease and focal segmental glomerulosclerosis.
    Garin EH; Reiser J; Cara-Fuentes G; Wei C; Matar D; Wang H; Alachkar N; Johnson RJ
    Pediatr Nephrol; 2015 Mar; 30(3):469-77. PubMed ID: 25239302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of B7-1 in podocytes is associated with nephrotic syndrome.
    Reiser J; von Gersdorff G; Loos M; Oh J; Asanuma K; Giardino L; Rastaldi MP; Calvaresi N; Watanabe H; Schwarz K; Faul C; Kretzler M; Davidson A; Sugimoto H; Kalluri R; Sharpe AH; Kreidberg JA; Mundel P
    J Clin Invest; 2004 May; 113(10):1390-7. PubMed ID: 15146236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The treatment of idiopathic focal segmental glomerulosclerosis in adults.
    Hogan J; Radhakrishnan J
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):434-41. PubMed ID: 25168833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.